REVB
Revelation Biosciences, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Revelation Biosciences (REVB) Stock: Buy, Sell, or Hold?
$3.92
-0.02 (-0.51%)
âŧ
5d:
-4.8%
30d:
+436.84%
90d:
+253.15%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
32/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$1.07 â $4.17
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-0.2x
Next 12M consensus est.
Wall Street Target
$136.50
+3364.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.43 / $4.75
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: REVB is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When REVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: REVB is currently trading at $3.92, which is considered slightly high relative to its 30-day fair value range of $1.07 to $4.17.
Technical Outlook: Technically, REVB is in a uptrend. Immediate support is located at $3.43, while resistance sits at $4.75.
Market Sentiment: REVB scores 11/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $136.50 (+3364.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, REVB is in a uptrend. Immediate support is located at $3.43, while resistance sits at $4.75.
Market Sentiment: REVB scores 11/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $136.50 (+3364.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.07 -
$4.17
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
Trading Range & Key Levels
30-Day Trading Range
$1.07 -
$4.17
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$3.43
Resistance Level
$4.75
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (11/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 3364.5% below Wall St target ($136.50)
- WARNING: Composite score 32/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.24
Wall Street Target
$136.50
(+3364.5%)
Share REVB Analysis
Share this live REVB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (REVB)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 1, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is currently flooded with bullish sentiment towards $REVB with no recent news articles to provide additional context.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:32 AM ET
Data refreshes hourly during market hours. Next update: 11:32 AM
Data refreshes hourly during market hours. Next update: 11:32 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 40 SELL |
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$302 | 49 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$592 | 37 SELL |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 72 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive REVB Research Pages
